{"id":49793,"date":"2022-10-19T13:02:24","date_gmt":"2022-10-19T11:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/"},"modified":"2022-10-19T13:02:24","modified_gmt":"2022-10-19T11:02:24","slug":"staar-surgical-to-report-third-quarter-results-on-november-2-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/","title":{"rendered":"STAAR Surgical to Report Third Quarter Results on November 2, 2022"},"content":{"rendered":"
\n

LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, <\/i><\/b>today announced that it will release financial results for the third quarter ended September 30, 2022 on Wednesday, November 2, 2022 <\/i><\/b>after the market close.\n<\/p>\n

<\/a><\/p>\n

\nSTAAR will host a conference call and webcast on Wednesday, November 2 at 4:30 p.m. Eastern \/ 1:30 p.m.<\/i><\/b> Pacific<\/b><\/i> to discuss its financial results and operational progress. To access the conference call (Access Code 976076), please dial 844-200-6205 for domestic participants and 929-526-1599 for international participants. The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com<\/a>.\n<\/p>\n

\nA taped replay of the conference call (Replay Code 710361) will be available beginning approximately one hour after the call\u2019s conclusion for seven days. This replay can be accessed by dialing 866-813-9403 for domestic callers and 929-458-6194 for international callers. An archived webcast will also be available at www.staar.com<\/a>.\n<\/p>\n

\nAbout STAAR Surgical<\/span><\/b>\n<\/p>\n

\nSTAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR\u2019s lens used in refractive surgery is called an Implantable Collamer\u00ae Lens or \u201cICL\u201d, which includes the EVO Visian ICL\u2122 product line. More than 2,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com<\/a>. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company\u2019s website at www.staar.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors & Media<\/b>
Brian Moore
\n
Vice President, Investor, Media Relations and Corporate Development
\n
(626) 303-7902, Ext. 3023
\n
bmoore@staar.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 30, 2022 on Wednesday, November 2, 2022 after the market close. STAAR will host a conference call … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49793","6":"format-standard","7":"category-industry"},"yoast_head":"\nSTAAR Surgical to Report Third Quarter Results on November 2, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"STAAR Surgical to Report Third Quarter Results on November 2, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 30, 2022 on Wednesday, November 2, 2022 after the market close. STAAR will host a conference call ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-19T11:02:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221019005015\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"STAAR Surgical to Report Third Quarter Results on November 2, 2022\",\"datePublished\":\"2022-10-19T11:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/\"},\"wordCount\":343,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005015\\\/en\\\/683092\\\/21\\\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/\",\"name\":\"STAAR Surgical to Report Third Quarter Results on November 2, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005015\\\/en\\\/683092\\\/21\\\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\",\"datePublished\":\"2022-10-19T11:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005015\\\/en\\\/683092\\\/21\\\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005015\\\/en\\\/683092\\\/21\\\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"STAAR Surgical to Report Third Quarter Results on November 2, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STAAR Surgical to Report Third Quarter Results on November 2, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/","og_locale":"en_US","og_type":"article","og_title":"STAAR Surgical to Report Third Quarter Results on November 2, 2022 - Pharma Trend","og_description":"LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 30, 2022 on Wednesday, November 2, 2022 after the market close. STAAR will host a conference call ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-19T11:02:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221019005015\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"STAAR Surgical to Report Third Quarter Results on November 2, 2022","datePublished":"2022-10-19T11:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/"},"wordCount":343,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221019005015\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/","url":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/","name":"STAAR Surgical to Report Third Quarter Results on November 2, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221019005015\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg","datePublished":"2022-10-19T11:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221019005015\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221019005015\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-to-report-third-quarter-results-on-november-2-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"STAAR Surgical to Report Third Quarter Results on November 2, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49793"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49793\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}